OXTR and prostate carcinoma: Several previous studies have demonstrated that the activation of OXTR-mediated signaling promotes or prevents tumorigenesis and metastasis in multiple cancers, including breast cancer, non-small-cell lung cancer, prostate cancer, and ovarian cancer [20,21,28,29].